We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$4.7M
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$4.09M
SI
3
Sofinnova Investments
California
$3.9M
AAA
4
Affinity Asset Advisors
New York
$3.52M -$145K -104,608 -3%
BlackRock
5
BlackRock
New York
$3.41M -$93.5K -67,422 -2%
RSCM
6
Rock Springs Capital Management
Maryland
$3.14M -$578K -416,684 -11%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.51M +$174K +125,229 +5%
NMC
8
NEA Management Company
Maryland
$2.22M
SB
9
Samsara BioCapital
California
$1.42M
Millennium Management
10
Millennium Management
New York
$1.13M -$884K -637,552 -34%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.12M +$70.9K +51,143 +4%
SFM
12
Sphera Funds Management
Israel
$1.08M
Fidelity Investments
13
Fidelity Investments
Massachusetts
$1.07M -$895K -645,806 -35%
BOCH
14
Blue Owl Capital Holdings
New York
$983K
WP
15
Woodline Partners
California
$913K +$852 +615 +0.1%
State Street
16
State Street
Massachusetts
$907K -$14.3K -10,350 -1%
DMKJ
17
David M. Knott Jr
$606K -$39.9K -28,796 -4%
Renaissance Technologies
18
Renaissance Technologies
New York
$514K +$198K +143,055 +34%
SVCM
19
Saturn V Capital Management
Texas
$454K -$1.21M -875,328 -64%
S
20
Sanofi
France
$403K
PFCS
21
Pale Fire Capital SE
Czech Republic
$401K +$308K +222,270 +102%
Northern Trust
22
Northern Trust
Illinois
$390K -$31.4K -22,640 -5%
Aberdeen Group
23
Aberdeen Group
United Kingdom
$297K +$217K +156,236 +92%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$229K -$350K -252,586 -50%
Goldman Sachs
25
Goldman Sachs
New York
$213K -$26.6K -19,161 -8%